The weekly litigation news digest is live. Subscribe now

IP Verse

Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof

Patent No. EP3346003 (titled "Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof") was filed by Toolgen Incorporated on Oct 23, 2013. The application was issued on Jun 9, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BASFMar 9, 2022EISENFUHR SPEISER
SCHLICHMar 9, 2022SCHLICH
GRUNDFeb 14, 2022GRUND

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3346003

TOOLGEN INCORPORATED
Application Number
EP17206792A
Filing Date
Oct 23, 2013
Status
Granted And Under Opposition
May 10, 2021
Publication Date
Jun 9, 2021
External Links
Slate, EP3346003B1, Google Patents